Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
about
Selective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentationFasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.All in the head: obstacles for immune rejection of brain tumours.STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells.
P2860
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@ast
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@en
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@nl
type
label
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@ast
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@en
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@nl
prefLabel
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@ast
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@en
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@nl
P2860
P1433
P1476
Fas ligand and the fate of antitumour cytotoxic T lymphocytes.
@en
P2093
Joe O'Connell
P2860
P304
P356
10.1046/J.1365-2567.2002.01379.X
P577
2002-03-01T00:00:00Z